ATC
KNSA icon

Adirondack Trust Company’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Adirondack Trust Company’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-875
Closed -$16.3K – 498
2024
Q2 		$16.3K Hold
875
– – 0.01% 320
2024
Q1 		$17.3K Hold
875
– – 0.01% 315
2023
Q4 		$18.5K Hold
875
– – 0.01% 308
2023
Q3 		$15.2K Hold
875
– – 0.01% 309
2023
Q2 		$16.5K Hold
875
– – 0.01% 285
2023
Q1 		$9.41K Hold
875
– – ﹤0.01% 338
2022
Q4 		$13.1K Hold
875
– – 0.01% 301
2022
Q3 		$11K Hold
875
– – 0.01% 310
2022
Q2 		$8K Hold
875
– – ﹤0.01% 336
2022
Q1 		$9K Buy
875
+445
+103% +$4.71K ﹤0.01% 327
2021
Q4 		$5K Buy
+430
New +$5.28K ﹤0.01% 356

Other funds holding KNSA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return